SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    British Cannabis launches first CBG product

    By

    British Cannabis™ has launched a new extension of its award-winning CBD Rescue Cream brand – Synergy CBG and CBD Rescue Cream®. 

    This range, in its original CBD formula, has been on the market since 2019, winning awards along the way and being the first cannabis cosmetic in the UK to undergo clinical trials for skin benefits.

    The product is featured on debuts on canabidol.com and marks the company’s first product release with added cannabigerol (CBG), a powerful, naturally extracted compound of the Cannabis sativa L. plant which, in combination with the attributes of the better-known CBD (cannabidiol) compound, brings a plethora of added benefits to skin.

    Steve Batchelor, Marketing Director at British Cannabis™, commented: “The UK’s first cannabis cosmetic to undertake clinical trials is now all the better from having an extra added active ingredient, CBG, in its formula. 

    “This range extension takes the Independent Community Pharmacist magazine’s CBD Product of The Year (2020) and enhances it with even more plant power.”

    Synergy CBD Rescue Cream® is a soft, natural cream delivered alongside two natural, legal cannabis plant extracts, Cannabidiol (CBD) and Cannabigerol (CBG), working together in synergy to create one of the most

    complete skin care products available today.

    On release, the Synergy Rescue Cream® range will be available at the following recommended retail prices:

    • Synergy CBG + CBD Rescue Cream® 250mg – £24.99 (November 2022)
    • Synergy CBG + CBD Rescue Cream® 500mg – £44.99 (November 2022)
    • Synergy+ CBG + CBD Rescue Cream® 250mg – £29.99 (2023)
    • Synergy+ CBG + CBD Rescue Cream® 500mg – £49.99 (2023)

    Synergy CBD Cream

    The market for CBD cosmetics is estimated to have reached over £180 million 2022 in the UK alone (CBD Intel), with growth predicted to exceed £250m by 2025.

    David Ralson, Managing Director for British Cannabis™, added: “Our consumers have relied on the CBD Rescue Cream® formula’s clinically proven ability to soothe, repair and restore damaged skin for three years. 

    “Now, with the purported anti-inflammatory benefits of CBG, the Rescue Cream® range is now an even better choice for those looking to defend their skin from the upcoming winter elements, which can greatly affect conditions like eczema. 

    “This formula is now also available to our White Label brand customers, so the power of CBD and CBG in synergy can be brought to other brands as well”.

    Thomas Whettem, CEO of British Cannabis™, added: “This is a formula that we have been excited about for quite a while. More still is in store for 2023, when Synergy+ (Synergy Plus) Rescue Cream debuts, with further topical benefits via the infusion of natural cannabis root extract. 

    “These extracts will be harvested from our very own European research hemp farm, another added benefit from all we do to bring people the best consumer cannabis products possible.”

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free